Assessing Neurological Health with Voice Biomarkers
Using AI-driven models to detect Multiple Sclerosis, Huntington's Disease, Parkinson's Disease, and more.
Canary Neurological™️: Elevating health screening with advanced vocal biomarkers
The healthcare industry often adopts a reactive approach to neurodegenerative diseases, focusing on managing symptoms once they become severe rather than identifying early indicators. This results in delayed diagnoses, missed opportunities for early intervention, and a higher burden on patients and families.
Transform Neurological Health with Canary Speech
Canary Neurological™️ is a clinical decision support system (CDSS) that uses objective voice biomarkers to screen for Multiple Sclerosis, Parkinson’s Disease, and Huntington’s Disease. Canary’s AI models monitor changes in speech patterns in both clinical and everyday environments quickly and unobtrusively. While a clinician employs Canary Ambient™️ or individual uses Canary Speech on a smart device, results are populated immediately after a normal conversation.
Available on
Access a license by contacting support@canaryspeech.com. Integration is fast and easy!




